April 5, 2019

April 05, 2019

What’s changed in the 10 years since the Tampa Bay Times’ first Top Workplaces survey

Tampa Bay Times – April 5

Sure enough, when the list hit my email, health care and financial services were well-represented, including some of the area’s marquee names — Moffitt Cancer Center, Raymond James Financial, PricewaterhouseCoopers.


Moffitt Cancer Center Receives $100K Research Grant

Bay News 9 – April 4

Researchers from the Moffitt Cancer Center in Tampa got a financial boost Wednesday which will allow them to continue their efforts to prevent and cure the deadly disease. 


Moffitt Donation

WTVT – April 3

The Kay Yow Cancer Fund donated $100,000 to the Moffitt Cancer Center for cancer research.


Former basketball coach teams up with Moffitt to raise thousands for cancer

WTSP – April 3

With the women's Final Four in town this weekend, The Kay Yow Cancer Fund and Moffitt Cancer Center are teaming up to fight the disease.


Kay Yow Cancer Fund gives $100K for Research

Spectrum News – April 3

The Moffitt Cancer Center received a $100,000 research grant from the Kay Yow Cancer Fund.


Clinical Oversight of Moffitt’s Clinical Pathways Program: Enabling Interdisciplinary Communication

Journal of Clinical Pathways – April 3

Journal of Clinical Pathways (JCP) spoke with Karen K Fields, MD, senior member, Breast Medical Oncology; medical director, Clinical Pathways and Value-Based Cancer Care, Moffitt Cancer Center (Tampa, FL). 


Hillsborough Community Day with NCAA

WTSP – April 3

They've got several stops to make... including middle schools and the Moffitt Cancer Center... while they recognize the championship


Next-generation TRK inhibitor demonstrates efficacy in tumors with emergent resistance mutations

Healio – April 2

I agree patients should seek this agent [BAY 2731954] when progressing on LOXO-101 with specific resistance mutations... - Damon Reed, MD, Moffitt Cancer Center


Encouraging pCR Rate Seen With T-VEC Plus Chemo in TNBC

Targeted Oncology – April 1

According to Hatem Soliman, MD, of Moffitt Cancer Center and Research Institute, who presented the findings during the 2019 AACR Annual Meeting, T-VEC was generally well tolerated, and relative dose intensity (RDI) of the chemotherapy approached 100%.


Coming Together Against Cancer’s Second Annual Event Set For April 13

Sarasota Magazine -  April 1

Coming Together Against Cancer (CTAC) has announced that four physicians will speak at its upcoming event on Saturday, April 13, from 9-11:30 a.m. at Eloise Werlin Park in Sarasota. They are Dr. Stephen Rosenberg (Moffitt Cancer Center), Dr. Annick Desjardins (Duke Cancer Institute), Dr. Michael Gorin (Johns Hopkins) and Dr. Kenneth Meredith (Sarasota Memorial Cancer Institute). 


Adding an Oncolytic Virus to Neoadjuvant Chemo for Triple-Negative Breast Cancer

Cancer Network – April 1

“Many have published data looking at the relationship between attaining a pathologic complete response [pCR] after neoadjuvant chemotherapy, and found that it is associated with an improved prognosis and reduced likelihood of recurrence,” said Hatem Soliman, MD, of the Moffitt Cancer Center in Tampa, Florida. 


What's next for newly named Uptown District in Tampa?

83 Degrees Media – April 1

“Presently, [Fowler Avenue] is a path for people where they move as quickly as they can through it, though many people use it to get to Moffitt Cancer Center, USF, or Busch Gardens,” Sharpe notes.


Early studies hint at some potential for CAR-T therapy in solid tumors

Biopharma Dive – March 31

Still, many groups, including the University of Pennsylvania, Seattle Children's Hospital and the Moffitt Cancer Center as well as Baylor and MSK, are advancing early-stage research efforts — some of which have been licensed to biotechs. 


Radiation Expert Highlights Role of Radioactive Iodine in Differentiated Thyroid Cancer

Targeted Oncology – March 29

In an interview with Targeted Oncology, Jimmy J. Caudell, MD, PhD, a radiation oncologist at Moffitt Cancer Center, discussed the role of radioactive iodine therapy in patients with DTC. He also highlighted areas of research that may help determine the best treatment regimens and doses for select patients.



Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.